Complicated Appendicitis: Clinical Trials

15 trials for Complicated Appendicitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 3 recruiting, 1 terminated, 1 unknown. 5 Not applicable, 4 Phase 4, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Recruiting 1, Unknown 1
Phase 44Completed 2, Recruiting 1, Terminated 1
Phase 32Completed 1, Recruiting 1
Phase 21Completed 1

Follow Complicated Appendicitis: new trials by email Literature Review of Complicated Appendicitis trials Research Report on Complicated Appendicitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Lactulose for Gastrointestinal Recovery After Complex Appendectomy
Lactulose oral solution, Placebo - Ileus Postoperative, Gastrointestinal Function
Not applicableRecruitingNanchong Central Hospital1502026-06-212026-06-25
Differences In Microbiota Profiles Of Pediatric Appendicitis Cases
Appendectomy - Appendicitis Acute, Disbiosis
Not applicableCompletedIstanbul University502025-08-182026-10-06
Laparoscopic Antibiotic Lavage to Prevent Intra-abdominal Abscess Formation in Complicated Appendicitis
Laparoscopic antibiotic peritoneal lavage with gentamicin / clindamycin - Complicated Appendicitis, Intra-Abdominal Abscess
Phase 3RecruitingSpaarne Gasthuis7522025-02-242026-10-09
New Diagnostic Markers In Dignosis Of Complicated Appendix
Bilirubin level sodium level c reactive protein level - Complicated Appendicitis
Not applicableUnknownSohag University502023-10-012023-10-26
Antibiotic Instillation in Appendicitis
Ceftriaxone, Intra-peritoneal Fluid Aspiration - Complicated Appendicitis, Acute Appendicitis
Phase 2CompletedJohns Hopkins All Children's Hospital1902023-01-052025-03-13
ERAS for Pediatric Acute Appendicitis
ERAS - Pediatric Disorder, Complicated Appendicitis
Not applicableCompletedFeng Jiexiong8932022-01-102023-12-08
Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics
Oral amoxicillin-clavulanic acid (40mg/kg in 3 times/day; maximum dose 3g/day), Inpatient postpoperative intravenous antibiotic treatment according to the established protocol in each center - Laparoscopic Appendectomy, Complicated Appendicitis
Phase 4RecruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau7722021-04-222026-09-08
Per Oral Versus Intravenous Postoperative Antibiotics After Surgery for Complicated Appendicitis.
Antibiotic - Complicated Appendicitis
Not applicableCompletedZealand University Hospital31932021-04-012024-10-01
Causes of Complicated Appendicitis at Referral Hospital
Complicated Appendicitis
CompletedHaramaya Unversity4022021-02-012021-08-13
Antibiotic Duration in Post-appendectomy Abscess
ampicillin/clavulanate - Complicated Appendicitis, Perforated Appendicitis
Phase 4TerminatedPhoenix Children's Hospital72019-05-012024-03-08
Complicated Appendicitis During the COVID-19 Pandemic in Jordan
Observational Study - COVID-19, Complicated Appendicitis
CompletedJordan University Hospital2572019-03-022022-05-16
Optimal Care of Complicated Appendicitis
Early Appendectomy, Interval Appendectomy, Antibiotics - Appendicitis, Perforated Appendicitis
Phase 4CompletedUniversity of Michigan402017-06-292023-11-28
Complicated Appendicitis in COVID-19 Era
impact of COVID-19 on Health-Seeking Behaviors - Covid19, Complicated Appendicitis
CompletedNational Taiwan University Hospital4652017-01-012021-08-19
Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections
Eravacycline, Meropenem, Placebo - Complicated Intra-abdominal Infections, Complicated Appendicitis
Phase 3CompletedTetraphase Pharmaceuticals, Inc5002016-10-132022-01-06
Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children
ceftriaxone, metronidazole/ampicillin, gentamicin, and metronidazole - Complicated Appendicitis
Phase 4CompletedHaEmek Medical Center, Israel432008-07-012012-09-05

Narrower conditions

Appendicitis (5)  ·  COVID-19 (2)  ·  Abdomen, Acute (1)  ·  Abdominal Abscess (1)  ·  Dysbiosis (1)  ·  Emergencies (1)  ·  Health Behavior (1)

Broader conditions

Infections (7)  ·  Cecal Diseases (5)  ·  Digestive System Diseases (5)  ·  Gastroenteritis (5)  ·  Gastrointestinal Diseases (5)  ·  Intestinal Diseases (5)  ·  Intraabdominal Infections (5)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pathologic Processes (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)

Interventions

Amoxicillin-Potassium Clavulanate Combination (3)  ·  Metronidazole (3)  ·  Ampicillin (2)  ·  Anti-Bacterial Agents (2)  ·  Ceftriaxone (2)  ·  Gentamicins (2)  ·  Piperacillin, Tazobactam Drug Combination (2)  ·  Appendectomy (1)  ·  Ciprofloxacin (1)  ·  Clavulanic Acid (1)  ·  Clindamycin (1)  ·  Lactulose (1)  ·  Meropenem (1)  ·  Observation (1)  ·  Piperacillin (1)

Sponsors

Feng Jiexiong (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  HaEmek Medical Center, Israel (1)  ·  Haramaya Unversity (1)  ·  Istanbul University (1)  ·  Johns Hopkins All Children's Hospital (1)  ·  Jordan University Hospital (1)  ·  Nanchong Central Hospital (1)  ·  National Taiwan University Hospital (1)  ·  Phoenix Children's Hospital (1)  ·  Sohag University (1)  ·  Spaarne Gasthuis (1)  ·  Tetraphase Pharmaceuticals, Inc (1)  ·  University of Michigan (1)  ·  Zealand University Hospital (1)

Countries

United States (4)  ·  China (2)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Estonia (1)  ·  Ethiopia (1)  ·  Georgia (1)  ·  Hungary (1)  ·  Israel (1)  ·  Jordan (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Netherlands (1)

Top investigators

Badhaasaa Bayissa, MD (1)  ·  Craig Egan, MD (1)  ·  Jiexiong Feng, MD (1)  ·  Maria Jose Martinez-Zapata, MD, PhD (1)  ·  Marzouq Amarin, MD, MSc (1)  ·  Nicole M. Chandler, MD (1)  ·  Steven W. Bruch, M.D. (1)

Results publications

PMID 30561562, PMID 31570004, PMID 39379540

NIH funding

2025 (1)